Collaboration Details

Title of Collaborative Activity:

Critical Path for Rare Neurodegenerative Diseases (CP-RND)

Description of Collaborative Activity:

Critical Path for Rare Neurodegenerative Diseases is a public-private partnership aimed at advancing the understanding of neurodegenerative diseases and supporting the development and regulatory review of treatments for amyotrophic lateral sclerosis (ALS) and other rare neurodegenerative diseases.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2022

NIH Participating Institutes/Centers/Office of the Director:

HHS Agency Collaborators on this Activity:

FDA